Antimicrobial resistance in bacterial sexually transmitted infections
Antimicrobial resistance (AMR) is becoming a serious threat in sexually transmitted infections (STIs), particularly for Neisseria gonorrhoeae and Mycoplasma genitalium, which are increasingly resistant to all available treatments—raising concerns they could become untreatable.
- Treatment failures are already being reported for these infections
- Treponema pallidum (syphilis) shows emerging resistance to macrolides
- Chlamydia trachomatis remains treatable, but resistance could develop
Without urgent action—including better surveillance, responsible antibiotic use, improved diagnostics, and development of new drugs and vaccines—common STIs could become much harder or even impossible to treat.
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!



